Porocel acquires Medicine Hat catalyst processing facility from Criterion
Porocel International has acquired the Medicine Hat catalyst processing plant in Canada's Alberta province from Criterion Catalysts & Technologies, officials confirmed on Thursday.
The Medicine Hat facility will be Porocels fourth catalyst regeneration, rejuvenation and ex-situ presulfurization plant globally, adding to its sites in Lafayette, Louisiana), Luxembourg and Singapore.
This acquisition strategically positions Porocel to service the growing Canadian catalyst market
, according to company officials.
Porocel says it will achieve growth with a focused, continued emphasis on HSE, and will be introducing new and innovative technologies tied to catalyst regeneration, rejuvenation, ex-situ presulfurization and other related catalyst processing technologies.
From the Archive